Meridian Bioscience to Hold Fourth Quarter and Full Year 2019 Financial Results Conference Call on November 7, 2019
October 16 2019 - 11:00AM
Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic
testing solutions and life science raw materials will report fourth
quarter and full year 2019 financial results Thursday, November 7,
2019.
Jack Kenny, Chief Executive Officer, and Bryan
Baldasare, Executive Vice President and Chief Financial Officer,
will host a conference call beginning at 10:00 a.m. Eastern Time to
discuss the results and answer questions.
To participate in the live call by telephone
from the U.S., dial (866) 443-5802, or from outside the U.S., dial
(513) 360-6924, and enter the audience pass code 9471778.
A replay will be available for 14 days beginning
at 1:00 p.m. Eastern Time on November 7, 2019 by dialing (855)
859-2056 or (404) 537-3406 and entering pass code
9471778.
About Meridian Bioscience, Inc.
Meridian is a fully integrated life science company that develops,
manufactures, markets and distributes a broad range of innovative
diagnostic products. We are dedicated to developing and delivering
better solutions that give answers with speed, accuracy and
simplicity that are redefining the possibilities of life from
discovery to diagnosis. Through discovery and development, we
provide critical life science raw materials used in immunological
and molecular tests for human, animal, plant, and environmental
applications. Through diagnosis, we provide diagnostic solutions in
areas including gastrointestinal and upper respiratory infections
and blood lead level testing. We build relationships and provide
solutions to hospitals, reference laboratories, research centers,
veterinary testing centers, physician offices, diagnostics
manufacturers, and biotech companies in more than 70 countries
around the world.
Meridian’s shares are traded on the NASDAQ
Global Select Market, symbol VIVO. Meridian’s website address is
www.meridianbioscience.com.
Contact: Bryan
BaldasareExecutive Vice President and Chief Financial
OfficerMeridian Bioscience, Inc.Phone: 513.271.3700Email:
mbi@meridianbioscience.om
Meridian Bioscience (NASDAQ:VIVO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Meridian Bioscience (NASDAQ:VIVO)
Historical Stock Chart
From Apr 2023 to Apr 2024